Public Company News

YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023

FY2023 Revenues Increased by Approximately 30% Year Over Year GAITHERSBURG, Md., April 18, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new ...

2023-04-18 19:00 3309

Cheetah Mobile Inc. Files Its Annual Report on Form 20-F

BEIJING, April 18, 2023 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), aChina-based IT company, today announced that it filed its annual report on Form 20-F for the fiscal year endedDecember 31, 2022, with the Securities and Exchange Commission on April 18, ...

2023-04-18 18:57 3251

TCL Wins 2023 Red Dot Award for TCL S6 Series Home Theatre Soundbar

Hearing is believing with immersive surround sound from the ultimate partner of TCL Mini LED QLED TVs HONG KONG, April 18, 2023 /PRNewswire/ -- TCL, a global top two TV brand and top 1 98-inch TV brand, is proud to announce its new TCL S6 Series Home Theatre Soundbar has won the prestigious Red ...

2023-04-18 18:00 4118

Gaotu Files 2022 Annual Report on Form 20-F

BEIJING, April 18, 2023 /PRNewswire/ -- Gaotu Techedu Inc. ("Gaotu" or the "Company") (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider inChina, today filed with the U.S. Securities and Exchange Commission its annual report on Form 20-F for the ...

2023-04-18 18:00 3403

Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration

- 'Daewoong Pharmaceutical enters research collaboration to discover a novel small molecule to target autoimmune diseases using fragment-based drug discovery and virtual high throughput screening SEOUL, South Korea and NOTTINGHAM, England, April 18, 2023 /PRNewswire/ -- Daewoong Pharmaceuti...

2023-04-18 17:16 4621

Maypharm's Hyalmass filler with Hybrid Technology obtained CE to hit Europe and America's market

SEOUL, South Korea and NEW YORK, April 18, 2023 /PRNewswire/ -- Being already popular onSouth Asia market, particularly in Vietnam, Philippines, Thailand, China, for Hybrid Technology and highly dense HA for long-lasting effect, Hyalmass filler obtains CE to properly enterEurope, America etc mark...

2023-04-18 17:14 3432

SUSE Expands Open, Interoperable Strategy with the Latest Version of Rancher

* SUSE delivers new milestones in performance, stability & security with the release of Rancher 2.7.2, with extensibility enhancements and an improved security posture to foster eco-system adoption * Latest Rancher Prime, SUSE's commercial enterprise subscription, innovations accelerate custo...

2023-04-18 15:00 2732

Ericsson reports first quarter results 2023

STOCKHOLM, April 18, 2023 /PRNewswire/ --  First quarter highlights – Executing in a challenging market * Group organic sales[1] were unchanged YoY. As expected, segment Networks organic sales[1] declined by -2%, driven by lower operator capex and inventory optimization among multiple customer...

2023-04-18 13:51 3912

ATEN Empowers Efficient BYOD Collaborations with New 4K Wireless Presentation Switches

The new wireless BYOD solution is perfectly suited for any corporate and education application TAIPEI, April 18, 2023 /PRNewswire/ -- ATEN International, the leading provider of KVM and AV/IT connectivity and management solutions, today announces the launch of two new4K wireless presentation swi...

2023-04-18 13:00 3068

Illumina Singapore continues to climb in Best Employers Award Reaching 7th Overall

Illumina is celebrating 25 years of global operations and 15 years in Singapore this April. SINGAPORE, April 18, 2023 /PRNewswire/ -- Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked 7th overall from 250 companies and 1st in Healthcare Equipment & Ser...

2023-04-18 12:41 3778

AACR 2023 | Ascentage Pharma Presents Results from Three Studies Underscoring Exploratory Efforts in Potential New Indications

SUZHOU, China and ROCKVILLE, Md., April 17, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it had released results from three preclinic...

2023-04-18 09:08 2448

GC Biopharma celebrates 'World Hemophilia Day'

* To display a large media façade on its Yong-in R&D Center YONGIN, South Korea, April 17, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, takes part in a campaign to celebrate World Hemophilia Day. The company announced that a l...

2023-04-18 09:03 2470

USANA Malaysia Donates MYR 40,000 to Local Flood Relief

Donation in partnership with Suriana Welfare Society Malaysia KUALA LUMPUR, Malaysia, April 18, 2023 /PRNewswire/ -- Heavy flooding in Johor has led USANA Malaysia to donateMYR 40,000 in relief funds for those affected by this natural disaster. Beyond this donation, the company and its Associates...

2023-04-18 08:24 2983

Innovent Announces Updated Data of Phase 1 Clinical Trial for IBI351 (KRAS[G12C] Inhibitor) as Monotherapy for Solid Tumors at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmolog...

2023-04-18 08:00 4294

Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2023-04-18 08:00 4180

Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2023-04-18 08:00 3218

PRA Group Appoints Experienced Leader Owen James as Global Investments Officer

James brings 30 years of industry experience, with the most recent 10 years at PRA Group. NORFOLK, Va., April 18, 2023 /PRNewswire/ -- PRA Group, Inc. (NASDAQ: PRAA) (the "Company), a global leader in acquiring and collecting nonperforming loans, has announced the appointment ofOwen James as glo...

2023-04-18 06:33 4491

JELD-WEN Announces Sale of Australasia Business to Platinum Equity for AU$688 Million

CHARLOTTE, N.C., April 18, 2023 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD), a leading global manufacturer of building products, today announced that it has completed its comprehensive review of strategic alternatives for its Australasia business and has entered into a definitive sale agr...

2023-04-18 05:30 4325

Top KingWin Ltd Announces Pricing of Initial Public Offering

GUANGZHOU, China, April 17, 2023 /PRNewswire/ -- Top KingWin Ltd ("Top KingWin" or the "Company") (Nasdaq: TCJH), a provider of capital market related education and support services, as well as advisory and transaction services in China, today announced the pricing of its initial public offering o...

2023-04-18 05:19 2836